FDA Inspection 935814 — The Nebraska Medical Center

The Nebraska Medical Center — FEI 3000210077

The FDA completed an inspection of The Nebraska Medical Center on June 23, 2015 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 23, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Omaha, NE (United States)